Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas
Conditions: Nasopharyngeal Carcinoma; Castrate Resistant Prostate Cancer; Gastric Cancer; Ovarian Clear Cell Carcinoma; Mesothelioma; Sarcoma; Non Hodgkin Lymphoma; B Cell Lymphoma; Epithelioid Sarcoma Intervention: Drug: APG-5918 Sponsor: Ascentage Pharma Group Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asbestosis | Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Lymphoma | Mesothelioma | Research | Sarcomas | Study